ATE254455T1 - Wassermischbare pharmazeutische zusammensetzungen enthaltend paclitaxel - Google Patents

Wassermischbare pharmazeutische zusammensetzungen enthaltend paclitaxel

Info

Publication number
ATE254455T1
ATE254455T1 AT99951559T AT99951559T ATE254455T1 AT E254455 T1 ATE254455 T1 AT E254455T1 AT 99951559 T AT99951559 T AT 99951559T AT 99951559 T AT99951559 T AT 99951559T AT E254455 T1 ATE254455 T1 AT E254455T1
Authority
AT
Austria
Prior art keywords
water
mixable
pharmaceutical compositions
compositions containing
containing paclitaxel
Prior art date
Application number
AT99951559T
Other languages
English (en)
Inventor
Joseph Rubinfeld
Rajashree Joshi
Ashok Y Gore
Rajesh Shrotriya
Original Assignee
Supergen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Supergen Inc filed Critical Supergen Inc
Application granted granted Critical
Publication of ATE254455T1 publication Critical patent/ATE254455T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AT99951559T 1998-10-30 1999-09-22 Wassermischbare pharmazeutische zusammensetzungen enthaltend paclitaxel ATE254455T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/183,199 US6017948A (en) 1998-10-30 1998-10-30 Water-miscible pharmaceutical compositions
PCT/US1999/021990 WO2000025775A1 (en) 1998-10-30 1999-09-22 Water-miscible pharmaceutical compositions of paclitaxel

Publications (1)

Publication Number Publication Date
ATE254455T1 true ATE254455T1 (de) 2003-12-15

Family

ID=22671864

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99951559T ATE254455T1 (de) 1998-10-30 1999-09-22 Wassermischbare pharmazeutische zusammensetzungen enthaltend paclitaxel

Country Status (11)

Country Link
US (1) US6017948A (de)
EP (1) EP1124549B1 (de)
JP (1) JP2002528494A (de)
CN (1) CN1178655C (de)
AT (1) ATE254455T1 (de)
AU (1) AU775158B2 (de)
CA (1) CA2345697A1 (de)
DE (1) DE69912983D1 (de)
IL (1) IL142720A (de)
MX (1) MXPA01004268A (de)
WO (1) WO2000025775A1 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6774278B1 (en) * 1995-06-07 2004-08-10 Cook Incorporated Coated implantable medical device
WO2002085337A1 (en) 2001-04-20 2002-10-31 The University Of British Columbia Micellar drug delivery systems for hydrophobic drugs
US6040330A (en) * 1999-01-08 2000-03-21 Bionumerik Pharmaceuticals, Inc. Pharmaceutical formulations of taxanes
US6136846A (en) * 1999-10-25 2000-10-24 Supergen, Inc. Formulation for paclitaxel
US6828346B2 (en) * 1999-10-25 2004-12-07 Supergen, Inc. Methods for administration of paclitaxel
CA2410632A1 (en) 2000-06-22 2001-12-27 David S. Garvey Nitrosated and nitrosylated taxanes, compositions and methods of use
AU2002240755B2 (en) * 2001-03-13 2007-07-05 Angiotech International Ag Micellar drug delivery vehicles and uses thereof
DE10115740A1 (de) * 2001-03-26 2002-10-02 Ulrich Speck Zubereitung für die Restenoseprophylaxe
US20030126788A1 (en) * 2001-11-07 2003-07-10 Colloid Tech. Inc. Storage stable translucent flammable article
AU2002365883A1 (en) * 2001-11-30 2003-06-17 Bristol-Myers Squibb Company Paclitaxel solvates
US6537985B1 (en) 2001-11-30 2003-03-25 Phoenix Scientific, Inc. Antibiotic formulation and a method of making this formulation
ATE424187T1 (de) * 2002-07-15 2009-03-15 Alcon Inc Bioerodierbare folie zur abgabe eines ophthalmischen arzneimittels
DE10244847A1 (de) 2002-09-20 2004-04-01 Ulrich Prof. Dr. Speck Medizinische Vorrichtung zur Arzneimittelabgabe
NZ565378A (en) 2005-06-29 2011-03-31 Threshold Pharmaceuticals Inc Phosphoramidate alkylator prodrugs
US9943490B2 (en) 2007-11-05 2018-04-17 The Trustees Of Princeton University Composite flash-precipitated nanoparticles
PL2231144T3 (pl) 2007-12-24 2014-12-31 Sun Pharma Advanced Res Co Ltd Nanodyspersja
JP5765634B2 (ja) 2008-10-21 2015-08-19 スレッシュホールド ファーマシューティカルズ， インコーポレイテッド 低酸素活性化型プロドラッグを用いるがんの処置
JP5627039B2 (ja) 2009-06-19 2014-11-19 サン・ファーマ・アドバンスド・リサーチ・カンパニー・リミテッド 薬物のナノ分散体およびその調製のための方法
BR112012028037A2 (pt) 2010-05-03 2016-08-02 Teikoku Pharma Usa Inc formulação de pró-emulsão líquida de taxano não aquosa, métodos para administrar um taxano a um paciente e para fabricar uma formulação de pró-emulsão de taxano, composição de emulsão de taxano, e, kit
WO2012092421A2 (en) * 2010-12-30 2012-07-05 Surmodics, Inc. Composition for intravascular delivery of therapeutic composition
JO3685B1 (ar) 2012-10-01 2020-08-27 Teikoku Pharma Usa Inc صيغ التشتيت الجسيمي للتاكسين غير المائي وطرق استخدامها
CN112972419B (zh) * 2019-12-02 2024-03-08 四川科伦药物研究院有限公司 一种白蛋白纳米药物组合物的制备方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE74244B1 (en) * 1985-10-01 1997-07-16 Bimeda Res Dev Ltd A process for preparing an antibiotic composition
US5034397A (en) * 1985-12-12 1991-07-23 Bristol-Myers Squibb Co. Stable, water soluble salt compositions of M-AMSA in 1-methyl-2-pyrrolidinone
US4772589A (en) * 1986-10-29 1988-09-20 Bristol-Myers Etoposide solution in NMP
AU630469B2 (en) * 1989-05-26 1992-10-29 Abbott Laboratories Injectable clarithromycin composition
US5082863A (en) * 1990-08-29 1992-01-21 Schering Corporation Pharmaceutical composition of florfenicol
CA2086874E (en) * 1992-08-03 2000-01-04 Renzo Mauro Canetta Methods for administration of taxol
EP0626171A1 (de) * 1993-05-26 1994-11-30 Winfried Dörnhöfer Injektionslösung für die intravenöse oder intramuskuläre Verabreichung an Tiere
TW406020B (en) * 1993-09-29 2000-09-21 Bristol Myers Squibb Co Stabilized pharmaceutical composition and its method for preparation and stabilizing solvent
NZ292690A (en) * 1994-09-01 1998-06-26 Upjohn Co Parenteral formulations comprising a lazaroid steroid, buffer, cosolvent and water
WO1996021427A1 (en) * 1995-01-09 1996-07-18 Atrix Laboratories, Inc. Liquid polymer delivery system
US5681846A (en) * 1995-03-17 1997-10-28 Board Of Regents, The University Of Texas System Extended stability formulations for paclitaxel
US5726181A (en) * 1995-06-05 1998-03-10 Bionumerik Pharmaceuticals, Inc. Formulations and compositions of poorly water soluble camptothecin derivatives
CN1104899C (zh) * 1995-12-21 2003-04-09 美国辉瑞有限公司 可注射喹诺酮制剂
US5773422A (en) * 1996-01-29 1998-06-30 Komer; Gene Avermectin formulation
US5877205A (en) * 1996-06-28 1999-03-02 Board Of Regents, The University Of Texas System Parenteral paclitaxel in a stable non-toxic formulation
CA2211949A1 (en) * 1997-07-21 1999-01-29 David Farley Johnson Nonaqueous compositions for parenteral administration
US5922754A (en) * 1998-10-02 1999-07-13 Abbott Laboratories Pharmaceutical compositions containing paclitaxel

Also Published As

Publication number Publication date
CN1368880A (zh) 2002-09-11
IL142720A (en) 2005-03-20
WO2000025775A1 (en) 2000-05-11
IL142720A0 (en) 2002-03-10
CA2345697A1 (en) 2000-05-11
MXPA01004268A (es) 2002-06-04
AU775158B2 (en) 2004-07-22
EP1124549B1 (de) 2003-11-19
CN1178655C (zh) 2004-12-08
AU6397799A (en) 2000-05-22
DE69912983D1 (de) 2003-12-24
JP2002528494A (ja) 2002-09-03
EP1124549A1 (de) 2001-08-22
US6017948A (en) 2000-01-25

Similar Documents

Publication Publication Date Title
ATE254455T1 (de) Wassermischbare pharmazeutische zusammensetzungen enthaltend paclitaxel
DE50004352D1 (de) Farbmittelzubereitungen
BR0215405A (pt) Composições e processos de uso de collajolie
PA8539901A1 (es) Novedosa sal de succinato de o-desmetil-venlafaxina
WO2004045001A3 (en) Organic light emitting materials and devices
NO20012739L (no) 3-substituerte-4-arylquinolin-2-on-derivater som kaliumkanal modulatorer
RS50660B (sr) Dihidrotetrabenazini i farmaceutske kompozicije koje ih sadrže
NO20003930L (no) Sammensetninger som inneholder organiske forbindelser
SV2004001432A (es) 2-tio-3,5-diciano-4-4fenil-6-aminopiridinas substituidas y su uso ref. lea 35 640-sv
NO20032252L (no) Piperazinylpyrazinforbindelser som agonist eller antagonist av serotonin 5HT-2-reseptor
DE59903442D1 (de) Azidfreie, gaserzeugende Zusammensetzung
EA199900373A2 (ru) Фармацевтические композиции
HRP20070374T3 (en) Formulations comprising ecteinascidin and a disaccharide
AR028162A1 (es) Disponibilidad controlada de compuestos de formulacion, composiciones y metodos para el lavado que utilizan los mismos.
RS50729B (sr) Preparat flastera induktora hipersenzitiviteta sa odloženim dejstvom i njegova primena
ES2126545T1 (es) Monomeros de epoxido reactivos curables cationicamente iniciados termicamente o por radiacion, y composiciones realizadas a partir de estos monomeros.
NO20031648D0 (no) Farmasöytiske lösninger av modafinilforbindelser
ECSP034531A (es) Derivados sustituidos de c-ciclohexilmetilamina
TWI256304B (en) Pharmaceutical compositions based on azetidine derivatives
BR0007922A (pt) Compostos calcilìticos
PA8577701A1 (es) Polipeptido t20 pegilado
DE69902493D1 (de) Härtbare, photochromische Zusammensetzung
ATE441626T1 (de) Azeotropähnliche zusammensetzungen und deren verwendung
EA200400670A1 (ru) Фармацевтические композиции, содержащие 3,4-пропинопергидропурины, и их применение для блокирования нейронной передачи
UY26556A1 (es) Compuestos calcilíticos

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties